From ileum to endocardium: a case report of Yersinia pseudotuberculosis prosthetic valve infective endocarditis Authors: Grace O’Dea, Carlos Sebastian Gracias, Nasser Monzer, Brendan McAdam, Julio Echarte, Wessam Ali, Edgar Francisco Carrizales Sepulveda, Deepti Ranganathan Published: 2026 ABSTRACT AbstractBackgroundWe report a case of Yersinia pseudotuberculosis prosthetic valve infective endocarditis (IE) in a 70-year-old woman. To date, Y. pseudotuberculosis IE has not been described in the literature.Case summaryThe patient presented with sepsis and a history of acute gastroenteritis, on a background of a long-standing mechanical mitral valve replacement (MVR) for rheumatic valve disease. Initial blood cultures grew Y. pseudotuberculosis, and a trans-oesophageal echocardiogram (TOE) demonstrated a mobile lesion suggestive of vegetations on the atrial surface of the MVR. Appropriate intravenous antibiotics were commenced with an improvement in both her serum markers and clinical status. The patient made a full clinical recovery, and follow-up imaging showed complete resolution of valvular lesions.DiscussionIn the setting of acute gastroenteritis among patients with prosthetic valves, clinicians must be vigilant for unusual gastro-intestinal organisms as a cause for infective endocarditis.Keywords: Case report, Infective endocarditis, Yersinia species, Prosthetic valve This is the first reported case of Yersinia pseudotuberculosis causing infective endocarditis. Clinicians should consider non-HACEK gram-negative bacteria in IE with gastrointestinal symptoms This is the first reported case of Yersinia pseudotuberculosis causing infective endocarditis. Clinicians should consider non-HACEK gram-negative bacteria in IE with gastrointestinal symptoms With targeted antibiotics and close follow-up, patients who are deemed at high risk for surgical intervention for prosthetic valve endocarditis can be treated effectively With targeted antibiotics and close follow-up, patients who are deemed at high risk for surgical intervention for prosthetic valve endocarditis can be treated effectively Early recognition of infective endocarditis and a multidisciplinary team approach to management is critical, particularly in more complex cases Early recognition of infective endocarditis and a multidisciplinary team approach to management is critical, particularly in more complex cases Introduction Over 100 years after William Osler remarked that ‘Few diseases present greater difficulties in the way of diagnosis than malignant endocarditis,’1 infectious endocarditis remains one of modern medicine’s great challenges. Infectious endocarditis, defined by infection of a native or prosthetic valve, the endocardium, or implantable cardiac device,2 has evolved over the last number of decades to reflect the ongoing advances in healthcare; we are now observing advanced age, immunosuppression, and nosocomial infection as the predominant factors in disease acquisition and severity.3,4 Yersinia species are a group of gram-negative bacilli, only three of which are found in human hosts.5 The most well-known of these is Yersinia pestis, causing the plague; however, Yersinia enterocolitica and Yersinia pseudotuberculosis are common causes of self-limiting gastroenteritis.6 Here, we describe the first reported case of infective endocarditis caused by Y. pseudotuberculosis in a patient with multiple comorbidities. Summary figure Created in BioRender. O'Dea, G. (2026) https://BioRender.com/xgtt0hc. Patient presentation A 70-year-old woman presented to the emergency department (ED) with a 3-day history of vomiting, diarrhoea, and poor oral intake. She had a background history of a mechanical St. Jude mitral valve replacement (MVR) 7 years prior for rheumatic valve disease with atrial fibrillation, and heart failure with reduced ejection fraction (HFrEF). She also had a history of recurrent falls with a previous subdural haemorrhage while on warfarin and epilepsy. Of note, she had no significant travel history, exposure to fresh water/hikes, and was not an intravenous drug user. She was anticoagulated in the community with therapeutic dose low-molecular weight heparin (enoxaparin 1.5 mg/kg once daily), as she was unable to tolerate warfarin. She was not on any immunosuppressive agents. A trans-thoracic echocardiogram (TTE) completed 4 months before her presentation showed a well seated MVR and a left ventricular ejection fraction of 45%. On presentation to the ED, she was hypotensive (84/50 mmHg), tachycardic (126bpm), and had a temperature of 38.9°C. She was notably drowsy, but physical examination did not yield any positive findings. Initial management in the ED was as per the local sepsis guidelines, with IV piperacillin-tazobactam and IV vancomycin commenced after peripheral blood and stool cultures were sent. She required inotropic support with noradrenaline to maintain an adequate blood pressure, and for this reason, she was admitted to the intensive care unit (ICU). Initial investigations Initial serological investigations showed raised inflammatory markers with a C-reactive protein (CRP) of 197 mg/L and a white-cell count (WCC) of 16 × 109/L. A chest radiograph on admission showed low lung volumes with no focal consolidation and bilateral old traumatic humerus fractures (Figure 1). Subsequent chest radiographs were also clear. Most notably, initial blood cultures cultured gram-negative bacilli after 21 h in the anaerobic bottle—later confirmed to be Y. pseudotuberculosis. Stool samples did not isolate any bacteria, including the Yersinia species. Mid-stream urine samples were negative. An electrocardiogram (ECG) on admission showed atrial fibrillation with a rapid ventricular response of 126 bpm. AP erect CXR showing low lung volumes, midline sternotomy wires and a mechanical mitral valve, and old bilateral humerus fractures with extensive degenerative changes. Management Following the results of blood cultures, antibiotic therapy was changed to IV cefuroxime and IV gentamicin as per Microbiology recommendations. At this point, she began to have melaena, but haemoglobin remained stable at 11.3 g/dL. An urgent computed tomography (CT) of the abdomen and pelvis showed a small volume of intraperitoneal fluid but no evidence of colitis. On day 3, the pathogen was identified as a Y. pseudotuberculosis, sensitive to amoxicillin [minimum inhibitory concentration (MIC)